New Hyde Park, NY, United States of America

Bishnu De

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bishnu De

Introduction

Bishnu De is a notable inventor based in New Hyde Park, NY (US). He has made significant contributions to the field of gene therapy, particularly in addressing alpha 1-antitrypsin (AAT) deficiency. His innovative work has the potential to impact many lives.

Latest Patents

Bishnu De holds a patent for an oxidation-resistant AAT gene therapy. This gene therapy treatment involves a plasmid or viral vector, such as an AAV, that codes for an elastase- or cathepsin G-inhibiting, oxidation-resistant human AAT. The therapy includes a substitution at specific sites, such as Met358 and/or Met351, which enhances its effectiveness.

Career Highlights

Bishnu De is affiliated with Cornell University, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative solutions in the field of gene therapy.

Collaborations

He has collaborated with notable colleagues, including Ronald G Crystal and Katie Stiles, who share his commitment to advancing medical science through innovative research.

Conclusion

Bishnu De's contributions to gene therapy exemplify the spirit of innovation in addressing critical health issues. His work continues to pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…